⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
globenewswire.com
CORT
CORT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CORT
Pomerantz LLP Informs Shareholders of Securities Class Action Filing Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman
prnewswire.com
CORT
DEADLINE ALERT for KD, PYPL, SMR, and CORT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
globenewswire.com
CORT
KD
PYPL
SMR
Lost Money on Corcept Therapeutics Incorporated(CORT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
prnewswire.com
CORT
Pomerantz LLP Informs Shareholders of Securities Class Action Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
CORT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CORT
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
globenewswire.com
CORT
CORT INVESTOR UPDATE: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
globenewswire.com
CORT